A global analysis of physical activity data from 68 countries shows large socioeconomic and gender inequalities in access to choice-based exercise, particularly active leisure. The study also ...

Initial treatments are underway in randomized study of Acorn’s personalized autologous injectable for improving facial ...

Cambridge researchers map the convergence of biomarkers, digital phenotyping, and AI toward biologically grounded ...

Poisoning deaths from "novel" benzodiazepines (NBZDs)—designed to mimic brand-name drugs like Valium and Xanax but with greater potency—have spiked in the last six years. Out of nearly 260 fatal ...

A peer-reviewed, multi-clinic study published in the Journal of Assisted Reproduction and Genetics suggests an ...

An updated systematic review of dozens of studies finds that Ginkgo biloba may offer modest short-term improvements for people with dementia, but shows little to no benefit for individuals with ...

The peer-reviewed invited review in Brain Medicine titled "New approaches to enhance the diagnosis of psychiatric disorders," is freely available via Open Access, starting on 10 March 2026 in Brain ...

Existing research on AI for mental health has many limitations. A new study shows this. Yet research is vital, so we must recalibrate. An AI Insider scoop.

Compounds found in cannabis could provide a new roadmap for treating the world’s most common chronic liver disorder, according to a study released by the Hebrew University of Jerusalem.

FDA's elevated meeting status signals transition from biomarker data discussions to Accelerated Approval discussions OS ...

Dr. Raza Bokhari, Executive Chairman & CEO will participate in panel discussions and highlight Company's AI-enabled Drug Development Strategy ...

A sweeping review of previous research suggests commonly prescribed opioids often provide only modest pain relief and may increase side effect risk.